
Essays on responsible research.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 108 | Founded | 2 years ago | Last Issue | 14 days ago |
| Active | |||||

Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read his entire series here.
Nascent lemon leaves
On reading Dynamics of natural selection preceding human vira...
Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read his entire series here.
A vista of yesteryear, Côte d’Azur
On reading A plan to restore trust in science f...
Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read his entire series here.
Any suggestions for a collective noun for double basses?
On reading High risk rese...
Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read his entire series here.
Spring fury
On reading COVID’s origins: what we do and don’t know by Marietjie Ven...
Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read his entire series here.
Hey Liberty, look behind you!
On re-reading Airborne transmission of highly pathog...
Subscribers, engagement, traffic and sponsorship for Biosafety Now.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Essays on responsible research.
Simon Wain-Hobson is an emeritus professor of Virology at the Institute Pasteur, Paris. With a PhD from the University of Oxford he moved to France in 1980. His team were the first to sequence the genome of the virus that causes AIDS.
.
You can find recent issues that have been published by Biosafety Now on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Biosafety Now, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biosafety Now as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biosafety Now using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Biosafety Now. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.